SCHEMBL1259804

SCHEMBL1259804

NC(=O)Cn1cccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4602946 0.75 CA12 (0.51)
SCHEMBL7324404 0.74 ALDH1A1 (0.50)
SCHEMBL2876964 0.74
SCHEMBL463115 0.74
SCHEMBL6333046 0.74 LMNA (0.44)
SCHEMBL9912386 0.73 KDM4E (0.50)
SCHEMBL4600542 0.72
SCHEMBL11680379 0.72
Hydrochloric Acid SCHEMBL6546580 0.72 ALDH1A1 (0.48)
Bromide SCHEMBL27471439 0.72 ALDH1A1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113816823-A Process for synthesizing chloroethylene by using mercury-free catalyst 山东新龙节能环保设备有限公司 2021-12-21 CN claimed
CN-1085893-A Process for preparing pyrrolidinylacetamide derivatives DAIICHI SEIYAKU CO (JP) 1994-04-27 CN claimed
EP-4469090-A1 ANTIBODY-CONJUGATED CHEMICAL INDUCERS OF DEGRADATION WITH HYDOLYSABLE MALEIMIDE LINKERS AND METHODS THEREOF Genentech Inc. (US) 2024-12-04 EP disclosed
WO-2023147328-A1 ANTIBODY-CONJUGATED CHEMICAL INDUCERS OF DEGRADATION WITH HYDOLYSABLE MALEIMIDE LINKERS AND METHODS THEREOF GENENTECH, INC. (US) 2023-08-03 WO disclosed
CN-115754113-A Method for detecting content of catalyst tetrabutylammonium bromide in piracetam intermediate and finished product through high performance liquid chromatography 东北制药集团股份有限公司 2023-03-07 CN disclosed
CN-112022816-B Piracetam tablet and preparation method thereof 河北君临药业有限公司 2022-08-12 CN disclosed
CN-113816823-A Process for synthesizing chloroethylene by using mercury-free catalyst 山东新龙节能环保设备有限公司 2021-12-21 CN disclosed
CN-112022816-A Piracetam tablet and preparation method thereof 河北君临药业有限公司 2020-12-04 CN disclosed
CN-109400515-A A kind of preparation method of the Piracetam based on continuous reaction 嘉兴市秀洲区洪合镇中学 2019-03-01 CN disclosed
CN-108236608-A Pharmaceutical composition of cannabidiol and vigabatrin and application thereof 汉义生物科技(北京)有限公司 2018-07-03 CN disclosed
CN-104693089-B Continuous preparation process method of N-acetate pyrrolidone 沈阳化工大学 2017-01-18 CN disclosed
US-5274089-A A estra-1,3,5(10)-triene derivative THE UPJOHN COMPANY (US) 1993-12-28 US disclosed
US-5196542-A Phospholipase A2 inhibitors THE UPJOHN COMPANY (US) 1993-03-23 US disclosed
US-5187299-A Phospholipase inhibitors; treating diabetes, obesity THE UPJOHN COMPANY (US) 1993-02-16 US disclosed
US-5145874-A Phospholipase inhibitor, hypoglycemic agent, antidiabetic, obesity THE UPJOHN COMPANY (US) 1992-09-08 US disclosed
US-4917826-A TREATING DIABETES AND OBESITY THE UPJOHN COMPANY (US) 1990-04-17 US disclosed
EP-0115424-B1 PYRROLE-2-ACETYLAMINO ACID DERIVATIVES McNeilab, Inc. (US) 1987-11-04 EP disclosed
EP-0115424-A1 Pyrrole-2-acetylamino acid derivatives McNeilab, Inc. (US) 1984-08-08 EP disclosed
US-4225613-A 1H-Pyrrole-1-acetamide compounds and their pharmaceutical compositions JOHN WYETH & BROTHER LIMITED (GB) 1980-09-30 US disclosed
US-4021566-A ANTISECRETORY, ANTIULCER STERLING DRUG INC. (US) 1977-05-03 US disclosed